Cargando…
Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety
BACKGROUND: Transfusion-transmitted infections (TTIs) are one of the biggest threats to blood transfusion safety. Nucleic acid testing (NAT) in blood donor screening has been implemented in many countries to reduce the risk of TTIs. NAT shortens this window period, thereby offering blood centers a m...
Autores principales: | Kumar, Rajesh, Gupta, Sonia, Kaur, Amarjit, Gupta, Manvi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562146/ https://www.ncbi.nlm.nih.gov/pubmed/26420945 http://dx.doi.org/10.4103/0973-6247.154250 |
Ejemplares similares
-
Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus
por: Shyamala, Venkatakrishna
Publicado: (2014) -
One window-period donation in two years of individual donor-nucleic acid test screening for hepatitis B, hepatitis C and human immunodeficiency virus
por: Levi, José Eduardo, et al.
Publicado: (2013) -
Individual donation nucleic acid technology testing to minimize human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus transfusion transmitted infections
por: Shyamala, Venkatakrishna, et al.
Publicado: (2014) -
Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors
por: Flichman, Diego M, et al.
Publicado: (2014) -
Comment on: One window-period donation in two years of individual
donor-nucleic acid test screening for hepatitis B, hepatitis C and human
immunodeficiency virus
por: Vermeulen, Marion
Publicado: (2013)